Recombinant GPC3 (Codrituzumab Biosimilar) antibody (PE)

Catalog No. ABIN7829166

The PE-conjugated Humanized Monoclonal anti-GPC3 (Codrituzumab Biosimilar) antibody (ABIN7829166) specifically detects GPC3 (Codrituzumab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant GPC3 (Codrituzumab Biosimilar) antibody (PE) (ABIN7829166)

Target: GPC3 (Codrituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This GPC3 (Codrituzumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-GPC3 (Codrituzumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-GPC3(codrituzumab biosimilar) mAb

Isotype: IgG1, kappa

Application Details

Application Notes: Flow Cyt 1:55

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid,PBS with 0.1 % Proclin300, 0.18 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for GPC3 (Codrituzumab Biosimilar)

Target: GPC3 (Codrituzumab Biosimilar)

Alternative Name: Codrituzumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:DGSX,GTR2-2,MXR7,OCI-5,SDYS,SGB,SGBS,SGBS1
Synonyms Antibody:GC33, RG7686, RO5137382

UniProt: P51654